AMGN
Amgen insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$402.98
+40.8% over 12 months
Share price and insider trades
AMGN closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$29.3M
Insiders buying0
Insiders selling6
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.1×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Amgen insiders reported open-market purchases totaling $0, while 6 insiders reported sales totaling $29.3M. 0 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 111 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 13SEC | Rachna KhoslaSvp, Business Development | Sell | 2,000 | $412.57 | $825K | -2.3% | — |
| Aug 13SEC | Rachna KhoslaSvp, Business Development | Sell | 1,252 | $416.43 | $521K | -3.2% | — |
| Aug 7SEC | Derek MillerSvp, Human Resources | Sell | 2,069 | $402.54 | $833K | +0.1% | — |
| Aug 7SEC | Nancy A. GrygielSvp & Cco | Sell | 1,970 | $402.16 | $792K | +0.2% | — |
| Aug 7SEC | Derek MillerSvp, Human Resources | Sell | 1,821 | $402.54 | $733K | +0.1% | — |
| Aug 7SEC | Nancy A. GrygielSvp & Cco | Sell | 1,000 | $402.16 | $402K | +0.2% | — |
| May 5SEC | Nancy A. GrygielSvp & Cco | Sell | 1,237 | $323.73 | $400K | +24.5% | — |
| Mar 2SEC | Esteban SantosEvp, Operations | Sell | 30,501 | $379.12 | $11.6M | +6.3% | — |
| Mar 2SEC | Esteban SantosEvp, Operations | Sell | 24,291 | $379.12 | $9.2M | +6.3% | — |
| Feb 20SEC | Matthew C. BuschVp, Finance & Cao | Sell | 1,000 | $375.79 | $376K | +7.2% | — |
| Nov 21SEC | Nancy A. GrygielSvp & Cco | Sell | 1,639 | $337.26 | $553K | +19.5% | — |
| Nov 21SEC | Nancy A. GrygielSvp & Cco | Sell | 1,500 | $337.26 | $506K | +19.5% | — |
| Nov 13SEC | Murdo GordonEvp, Global Commercial Ops | Sell | 6,879 | $336.83 | $2.3M | +19.6% | — |
| Nov 13SEC | Rachna KhoslaSvp, Business Development | Sell | 890 | $336.24 | $299K | +19.8% | — |
Insiders at Amgen
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Esteban SantosEvp, Operations | — | $20.8M | May 11, 2026 | — |
| Nancy A. GrygielSvp & Cco | — | $2.7M | Aug 7, 2026 | — |
| Murdo GordonEvp, Global Commercial Ops | — | $2.3M | May 11, 2026 | — |
| Rachna KhoslaSvp, Business Development | — | $1.6M | Aug 13, 2026 | — |
| Derek MillerSvp, Human Resources | — | $1.6M | Aug 7, 2026 | — |
| Matthew C. BuschVp, Finance & Cao | — | $376K | Aug 12, 2026 | — |
| Michael V DrakeDirector | — | — | Aug 10, 2026 | — |
| Charles M HolleyDirector | — | — | Aug 10, 2026 | — |
| Omar IshrakDirector | — | — | Aug 10, 2026 | — |
| Wanda M AustinDirector | — | — | May 21, 2026 | — |
| Brian DrukerDirector | — | — | May 21, 2026 | — |
| Robert EckertDirector | — | — | May 21, 2026 | — |
| Greg C. GarlandDirector | — | — | May 21, 2026 | — |
| Tyler JacksDirector | — | — | May 21, 2026 | — |
| Mary E. KlotmanDirector | — | — | May 21, 2026 | — |
| Ellen Jamison KullmanDirector | — | — | May 21, 2026 | — |
| Amy E MilesDirector | — | — | May 21, 2026 | — |
| Robert A BradwayCEO, President | — | — | May 11, 2026 | — |
| Peter H. GriffithCFO | — | — | May 11, 2026 | — |
| David M ReeseCTO | — | — | May 11, 2026 | — |
| Jonathan P GrahamEvp & Gen. Counsel & Sec. | — | — | May 11, 2026 | — |
| James E. BradnerEvp, Research And Development | — | — | May 11, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about AMGN insiders
Are Amgen insiders buying AMGN stock?
In the past 12 months, 0 insiders reported open-market purchases of AMGN worth $0.
Are Amgen insiders selling AMGN stock?
6 insiders reported sales worth $29.3M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.